Page 111 - Puneet Wadhwa

Capital Goods: Not out of the woods yet

Analysts are of the opinion that performance in Q2 will not be very different from that in Q1

The curious case of the Indian stock market

Despite negative global cues, Indian markets remain resilient

Prolonged US govt shutdown can impact emerging market flows: Puneet Chaddha

Interview with CEO, HSBC AMC

Lalu Yadav convicted: More fodder for the markets in the election year?

While the market participants will fine-tune their investment strategy in-line with how key economic policies take shape the global and domestic level, most are also keeping a tab on how the political

Market players hope to cheer their Oktoberfest

While September saw the markets react to FOMC and RBI moves, October could be another blockbuster month

What to expect from Financial Technologies AGM today

Deloitte yesterday said FY13 accounts can't be relied upon due to NSEL crisis

Defensive stocks outperform again

Beat benchmark indices for the fourth year but most analysts still caution one must be careful while investing in this space

Real estate stocks present pockets of opportunity

Despite high inventory & slowing demand, there are some investment worthy picks

Bernanke may opt for mild taper. Raghuram Rajan may hold rates steady

Reserve Bank of India (RBI) will review its Monetary Policy a day later, and to a large extent will be dependent on the outcome of the US Fed meet

After Bernanke, can Raghuram Rajan now surprise the markets?

After the initial euphoria in the markets settles, all eyes will now be on Raghuram Rajan as the RBI's reviews the Monetary Policy on Friday

FOMC taper: The official release

US Fed decided not to start tapering its $85-billion bond buying programme

Clarity from Fed will calm markets: Edward Teather

Interview with Executive Director, UBS Investment Bank

Ranbaxy: New product launches, margins to be hit

The company is capacity constrained as Ohm Laboratories plant in the US is its only US-FDA approved option left after the Mohali import alert

Ranbaxy slips 30% on fresh US FDA warning. Avoid, say analysts

Pharma major's fresh troubles with US FDA is a major setback after the recent revival

Banking sector hiring dips for the third month

Banking and financial services sector has been showing continuous dip in hiring activity for 3 months now

Fed's quantitavie easing taper is reasonably priced in: Abhay Laijawala

Interview with MD & head of research, Deutsche Equities India

Riding the rally in BSE 500 stocks

Nearly 220 recover from 52-week lows; however, analysts suggest selective investment makes sense

Will the market rally last?

Hard to tell, for although these have bounced back from recent lows, markets might not be out of the woods yet, say analysts

Technical Calls: Two stocks that can give you 15-20% return

Check out the stocks you can buy and sell at the current levels with Shubham Agarwal, head - technical equities and associate vice- president, Motilal Oswal Securities

Buying property? 15 things you need to take note of

Before you sign on the dotted line, here are a few things that you need to keep in mind.